A large-scale multicentre cerebral diffusion tensor imaging study in amyotrophic lateral sclerosis

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 87, Issue 6, 2016, Pages 570-579

  Müller, Hans Peter ^a   Turner, Martin R ^b   Grosskreutz, Julian ^c   Abrahams, Sharon ^d   Bede, Peter ^e   Govind, Varan ^f   Prudlo, Johannes ^g   Ludolph, Albert C ^a   Filippi, Massimo ^h   Kassubek, Jan ^a  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c JENA UNIVERSITY HOSPITAL   (Germany)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e TRINITY COLLEGE DUBLIN   (Ireland)

^f UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF ROSTOCK   (Germany)

^h VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BRAIN MAPPING; BRAIN STEM; CONTROLLED STUDY; DIFFUSION TENSOR IMAGING; DISEASE SEVERITY; FEMALE; FRONTAL LOBE; HIPPOCAMPUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; PYRAMIDAL TRACT; WHITE MATTER; ALGORITHM; BRAIN; CLINICAL TRIAL; COHORT ANALYSIS; COMPUTER ASSISTED DIAGNOSIS; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; MIDDLE AGED; MULTICENTER STUDY; NERVE CELL NETWORK; PROGNOSIS; RETROSPECTIVE STUDY;

BIOLOGICAL MARKER;

ALGORITHMS; AMYOTROPHIC LATERAL SCLEROSIS; BIOMARKERS; BRAIN; COHORT STUDIES; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; NERVE NET; PROGNOSIS; RETROSPECTIVE STUDIES; WHITE MATTER;

EID: 84974588587     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2015-311952     Document Type: Article

References (50)

1. Agosta F, Chiò A, Cosottini M, et al. The present, and the future of neuroimaging in amyotrophic lateral sclerosis. AJNR Am J Neuroradiol 2010; 31: 1769-77.
2. Bede P, Hardiman O. Lessons of ALS imaging: pitfalls, and future directions-A critical review. Neuroimage Clin 2014; 4: 436-43.
3. Kassubek J, Ludolph AC, Müller HP. Neuroimaging of motor neuron diseases. Ther Adv Neurol Disord 2012; 5: 119-27.
4. Keil C, Prell T, Peschel T, et al. Longitudinal diffusion tensor imaging in amyotrophic lateral sclerosis. BMC Neurosci 2012; 13: 141-52.
5. Turner MR, Agosta F, Bede P, et al. Neuroimaging in amyotrophic lateral sclerosis. Biomark Med 2012; 6: 319-37.
6. Le Bihan D, Mangin JF, Poupon C, et al. Diffusion tensor imaging: concepts, and applications. J Magn Reson Imaging 2001; 13: 534-46.
7. Brettschneider J, Del Tredici K, Toledo JB, et al. Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann Neurol 2013; 74: 20-38.
8. Kassubek J, Müller HP, Del Tredici K, et al. Diffusion tensor imaging analysis of sequential spreading of disease in amyotrophic lateral sclerosis confirms patterns of TDP-43 pathology. Brain 2014; 137: 1733-40.
9. Pettit LD, Bastin ME, Smith C, et al. Executive deficits, not processing speed relates to abnormalities in distinct prefrontal tracts in amyotrophic lateral sclerosis. Brain 2013; 136: 3290-304.
10. Sarro L, Agosta F, Canu E, et al. Cognitive functions, and white matter tract damage in amyotrophic lateral sclerosis: a diffusion tensor tractography study. AJNR Am J Neuroradiol 2011; 32: 1866-72.
11. Turner MR, Kiernan MC, Leigh PN, et al. Biomarkers in amyotrophic lateral sclerosis. Lancet Neurol 2009; 8: 94-109.
12. Turner MR, Benatar M. Ensuring continued progress in biomarkers for amyotrophic lateral sclerosis. Muscle Nerve 2015; 51: 14-18.
13. Turner MR, Grosskreutz J, Kassubek J, et al. Towards a neuroimaging biomarker for amyotrophic lateral sclerosis. Lancet Neurol 2011; 10: 400-3.
14. Menke RA, Körner S, Filippini N, et al. Widespread grey matter pathology dominates the longitudinal cerebral MRI, and clinical landscape of amyotrophic lateral sclerosis. Brain 2014; 137: 2546-55.
15. Vollmar C, O Muircheartaigh J, Barker GJ, et al. Identical, but not the same: intra-site, and inter-site reproducibility of fractional anisotropy measures on two 3.0T scanners. Neuroimage 2010; 51: 1384-94.
16. Teipel SJ, Reuter S, Stieltjes B, et al. Multicentre stability of diffusion tensor imaging measures: a European clinical, and physical phantom study. Psychiatry Res 2011; 194: 363-71.
17. Brooks BR, Miller RG, Swash M, et al. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000; 1: 293-9.
18. Ludolph A, Drory V, Hardiman O, et al A revision of the El Escorial criteria-2015. Amyotroph Lateral Scler Frontotemporal Degener 2015; 16: 291-2.
19. Cedarbaum JM, Stambler N, Malta E, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 1999; 169: 13-21.
20. Müller HP, Süssmuth SD, Landwehrmeyer GB, et al. Stability effects on results of diffusion tensor imaging analysis by reduction of the number of gradient directions due to motion artifacts: an application to presymptomatic Huntington s disease. PLoS Curr 2011; 3: RRN1292.
21. Shen Y, Larkman DJ, Counsell S, et al. Correction of high-order eddy current induced geometric distortion in diffusion-weighted echo-planar images. Magn Reson Med 2004; 52: 1184-9.
22. Müller HP, Kassubek J. Diffusion tensor magnetic resonance imaging in the analysis of neurodegenerative diseases. J Vis Exp 2013; 77.
23. Müller HP, Unrath A, Huppertz HJ, et al. Neuroanatomical patterns of cerebral white matter involvement in different motor neuron diseases as studied by diffusion tensor imaging analysis. Amyotroph Lateral Scler 2012; 13: 254-64.
24. Müller HP, Kassubek J, Grön G, et al. Impact of the control for corrupted diffusion tensor imaging data in comparisons at the group level: an application in Huntington disease. Biomed Eng Online 2014; 13: 128.
25. Foerster BR, Welsh RC, Feldman EL. 25 years of neuroimaging in amyotrophic lateral sclerosis. Nat Rev Neurol 2013; 9: 513-24.
26. Foerster BR, Dwamena BA, Petrou M, et al. Diagnostic accuracy of diffusion tensor imaging in amyotrophic lateral sclerosis: a systematic review, and individual patient data meta-Analysis. Acad Radiol 2013; 20: 1099-106.
27. Salat DH, Tuch DS, Greve DN, et al. Age-related alterations in white matter microstructure measured by diffusion tensor imaging. Neurobiol Aging 2005; 26: 1215-27.
28. Lim S, Han CE, Uhlhaas PJ, et al. Preferential detachment during human brain development: age-, and sex-specific structural connectivity in Diffusion Tensor Imaging (DTI) data. Cereb Corte 2015; 25: 1477-89.
29. Oouchi H, Yamada K, Sakai K, et al. Diffusion anisotropy measurement of brain white matter is affected by voxel size: underestimation occurs in areas with crossing fibers. AJNR Am J Neuroradiol 2007; 28: 1102-6.
30. Rosskopf J, Müller HP, Dreyhaupt J, et al. Ex post facto assessment of diffusion tensor imaging metrics from different MRI protocols: preparing for multicentre studies in ALS. Amyotroph Lateral Scler Frontotemporal Degener 2015; 9: 1-10.
31. Genovese CR, Lazar NA, Nichols T. Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage 2002; 15: 870-8.
32. Kunimatsu A, Aoki S, Masutani Y, et al. The optimal trackability threshold of fractional anisotropy for diffusion tensor tractography of the corticospinal tract. Magn Reson Med Sci 2004; 3: 11-17.
33. Filippini N, Douaud G, Mackay CE, et al. Corpus callosum involvement is a consistent feature of amyotrophic lateral sclerosis. Neurology 2010; 75: 1645-52.
34. Braak H, Brettschneider J, Ludolph AC, et al. Amyotrophic lateral sclerosis-A model of corticofugal axonal spread. Nat Rev Neurol 2013; 9: 708-14.
35. Fox RJ, Sakaie K, Lee JC, et al A validation study of multicenter diffusion tensor imaging: reliability of fractional anisotropy, and diffusivity values. AJNR Am J Neuroradiol 2012; 33: 695-700.
36. Jovicich J, Marizzoni M, Bosch B, et al. Multisite longitudinal reliability of tract-based spatial statistics in diffusion tensor imaging of healthy elderly subjects. Neuroimage 2014; 101: 390-403.
37. Müller HP, Grön G, Sprengelmeyer R, et al. Evaluating multicentre DTI data in Huntington s disease on site specific effects: an ex post facto approach. Neuroimage Clin 2013; 2: 161-7.
38. Walker L, Curry M, Nayak A, et al. Brain Development Cooperative Group A framework for the analysis of phantom data in multicenter diffusion tensor imaging studies. Hum Brain Mapp 2013; 34: 2439-54.
39. Veenith TV, Carter E, Grossac J, et al. Inter subject variability, and reproducibility of diffusion tensor imaging within, and between different imaging sessions. PLoS ONE 2013; 8: e65941.
40. Dyrba M, Ewers M, Wegrzyn M, et al. Robust automated detection of microstructural white matter degeneration in Alzheimer s disease using machine learning classification of multicenter DTI data. PLoS ONE 2013; 8: e64925.
41. Hobbs NZ, Cole JH, Farmer RE, et al. Evaluation of multi-modal, multi-site neuroimaging measures in Huntington s disease: Baseline results from the PADDINGTON study. Neuroimage Clin 2012; 2: 204-11.
42. Nir TM, Jahanshad N, Villalon-Reina JE, et al., Alzheimer s Disease Neuroimaging Initiative (ADNI). Effectiveness of regional DTI measures in distinguishing Alzheimer s disease, MCI, and normal aging. Neuroimage Clin 2013; 3: 180-95.
43. Agosta F, Pagani E, Petrolini M, et al. Assessment of white matter tract damage in patients with amyotrophic lateral sclerosis: a diffusion tensor MR imaging tractography study. AJNR Am J Neuroradiol 2010; 31: 1457-61.
44. Chiò A, Pagani M, Agosta F, et al. Neuroimaging in amyotrophic lateral sclerosis: insights into structural, and functional changes. Lancet Neurol 2014; 13: 1228-40.
45. Smith MC. Nerve fibre degeneration in the brain in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 1960; 23: 269-82.
46. Van Laere K, Vanhee A, Verschueren J, et al. Value of 18fluorodeoxyglucosepositron-emission tomography in amyotrophic lateral sclerosis: a prospective study. JAMA Neurol 2014; 71: 553-61.
47. Foerster BR, Feldman EL A brighter future for patients with amyotrophic lateral sclerosis through imaging?. JAMA Neurol 2014; 71: 539-40.
48. Brownell B, Oppenheimer DR, Hughes JT. The central nervous system in motor neurone disease. J Neurol Neurosurg Psychiatry 1970; 33: 338-57.
49. Miller KL, Stagg CJ, Douaud G, et al. Diffusion imaging of whole, post-mortem human brains on a clinical MRI scanner. Neuroimage 2011; 57: 167-81.
50. Jucker M, Walker LC. Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature 2013; 501: 45-51.